All Pharma articles – Page 21
-
HSJ LocalGPs privately urged to prescribe Tamiflu despite concerns
WORKFORCE: NHS England is encouraging GPs to prescribe Tamiflu to care and nursing home patients as a preventative measure, despite concerns about its effectiveness.
-
NewsNHS England delays access to NICE approved drug
Patients will be put at risk of developing cancer after NHS England was granted permission to delay access to a groundbreaking cure for hepatitis C, patient groups have warned.
-
NewsCancer drugs fund will need to cut more treatments, chair warns
Treatments available through the cancer drugs fund will have to continue being cut, the NHS England official in charge of the fund has said.
-
NewsCancer drugs fund receives surprise £60m boost
NHS England has announced a surprise £60m boost to the cancer drugs fund, bringing it up to £340m for 2015-16, even as it slashes the number of drugs available.
-
NewsNHS England drops treatments scorecard following legal threat
NHS England has dropped a controversial scorecard that was supposed to help it make decisions about whether to fund treatments for a number of rare conditions
-
NewsAppeal finds NICE decision on £90k breast cancer drug 'unfair'
The impact of the government’s drug pricing deal on patient access to new medicines has been thrown into confusion after a pharmaceutical company’s appeal against the decision to ban routine NHS funding of one of its drugs was upheld.
-
CommentPharmacists as care givers can make the forward view come true
A chance for new models of care
-
-
NewsCarter's procurement review to scrutinise temporary staff costs
A government backed review of NHS procurement has been expanded to examine the “concerning” rise in temporary staff bills, its head has revealed to HSJ.
-
NewsNHS England chief defines 'multispecialty community providers'
The NHS England chief executive has set out nine requirements that define a ‘multispecialty community provider’, one of the key care models in his vision for the future of the NHS.
-
NewsExclusive: NHS England delays treatment choices after legal threat
NHS England has cancelled key meetings at which it was due to decide whether to fund a series of treatments for serious conditions following a threat of judicial review, HSJ has learned.
-
NewsCCGs poised to defy pharma by switching to cheaper, unlicensed drug
Clinical commissioning groups across England are mulling the use of an unlicensed drug which could save the NHS millions of pounds, HSJ has learned
-
NewsNew NHS England partnership with pharma to speed up drug access
Government plans for closer working between the NHS and the pharmaceutical industry will make the new generation of precision medicines more affordable for the NHS, the minister for life sciences has said.
-
SupplementsSurvey results: putting pathology services to the test
How can healthcare organisations get the greatest benefit from pathology?
-
-
NewsPatients 'denied treatments' because of 'Kafkaesque' commissioning regime
Patients are being denied access to life changing treatments because parts of NHS England’s “Kafkaesque” commissioning regime appear to have ground to a halt, clinicians and charities have warned
-
NewsExpensive drugs to be cut from cancer drugs fund
NHS England is to start evaluating the cost effectiveness of medicines available through the cancer drugs fund in a bid to bring the budget under control
-
NewsExclusive: Labour could make NICE guidance mandatory
A Labour government could reduce variation in access to drugs and procedures by making it mandatory for commissioners to follow NICE guidelines, Andy Burnham has revealed
-
HSJ Local
Bath GPs to launch diabetes drug trial
CLINICAL RESEARCH: A network of GP surgeries around Bath has been selected as the site of a clinical trial for a diabetes drug from the pharmaceutical giant Pfizer.
-
NewsReturned drug money should not fund waiting list drive
The billions of pounds due to be clawed back from pharma firms under a new NHS pricing deal should not be diverted to help hospitals cut waiting lists, the head of the Association of British Pharmaceutical Industry has urged.